CoQ10 deficiency diseases in adults
Catarina M Quinzii1, Michio Hirano, Salvatore DiMauro
1Department of Neurology, Columbia University Medical Center, P&S 4-420, 630 West 168th street, New York, NY 10032, USA.
Mitochondrion
|May 9, 2007
Summary
Coenzyme Q10 (CoQ10) deficiency in muscles causes various diseases, mainly in children. The genetic causes of adult-onset CoQ10 deficiency remain unknown, unlike the infantile form.
Area of Science:
- Biochemistry
- Genetics
- Neurology
Background:
- Coenzyme Q10 (CoQ10) deficiency in muscle is linked to several diseases.
- These conditions include infantile-onset multisystemic diseases, encephalomyopathies, cerebellar ataxia, and myopathy.
- While CoQ10 deficiency primarily affects children, adult-onset cases of cerebellar ataxia and myopathy have been reported.
Purpose of the Study:
- To investigate the molecular genetic basis of Coenzyme Q10 deficiency.
- To identify the genetic causes of adult-onset CoQ10 deficiency.
- To differentiate the genetic underpinnings of infantile versus adult-onset CoQ10 deficiency.
Main Methods:
- Genetic analysis of patients with CoQ10 deficiency.
- Mutation screening in CoQ10 biosynthetic genes.
- Comparison of genetic findings between infantile and adult-onset cases.
Main Results:
- Mutations in COQ2 and PDSS2 genes are identified in infantile CoQ10 deficiency.
- The genetic causes for adult-onset CoQ10 deficiency have not yet been defined.
- A gap in knowledge exists regarding the molecular basis of adult-onset forms.
Conclusions:
- Infantile CoQ10 deficiency has known genetic links (COQ2, PDSS2).
- The genetic etiology of adult-onset CoQ10 deficiency requires further investigation.
- Understanding these genetic bases is crucial for diagnosis and potential therapies.
Related Concept Videos
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:30Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:17Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:26Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...